On July 23, 2019, together with MESSILA – Medical Startup Academy, we hosted a joint workshop for medical technology companies. Ron Kimhi held a lecture on entry to the US market and
Kengo Akano about entry to the Japanese market.
ERM advises Kedma Capital on the sale of its stake in Femi Premium to London-based private equity fund G Square Capital. Nimrod Rosenblum, Partner and Head of ERM’s Corporate and M&A practice, acted for Kedma Capital together with Jeremy Seeff, and Adi Garmazi. For more information (Hebrew) click here
ERM advised Pan-European chemicals supplier Azelis on its strategic entry to Israel with the acquisition of specialty chemicals distributor Orokia. Nimrod Rosenblum, Partner and Head of ERM’s Corporate and M&A practice, acted for Azelis together with associates Itamar Lev, Eti Avnery and Errel Peli. For more information on the acquisition click here (Azelis)